ALBHF OTC
Alibaba Health Information Technology Limited
1W: -5.6%
1M: -9.2%
3M: -14.6%
YTD: -47.6%
1Y: -57.5%
3Y: -47.3%
5Y: -80.7%
$0.36
+0.00 (+1.27%)
Weekly Expected Move ±12.0%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$33.0B
+8.0% ▲
5Y CAGR: +16.3%
Gross Profit
$7.9B
+6.5% ▲
5Y CAGR: +17.0%
Operating Income
$1.8B
+12.3% ▲
5Y CAGR: +97.7%
Net Income
$1.9B
+30.3% ▲
5Y CAGR: +39.9%
EPS (Diluted)
$0.11
+23.9% ▲
5Y CAGR: +33.2%
EBITDA
$1.8B
+12.4% ▲
5Y CAGR: +103.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $20.6B | $26.8B | $27.0B | $30.6B | $33.0B |
| YoY Growth | +32.6% | +30.1% | +1.0% | +13.2% | +8.0% |
| Cost of Revenue | $16.5B | $21.1B | $21.1B | $23.2B | $25.1B |
| Gross Profit | $4.1B | $5.7B | $5.9B | $7.4B | $7.9B |
| Gross Margin | 20.0% | 21.3% | 21.8% | 24.3% | 24.0% |
| R&D Expenses | $729M | $678M | $705M | $720M | $760M |
| SG&A Expenses | $2.4B | $2.1B | $2.1B | $2.6B | $5.4B |
| Operating Expenses | $5.1B | $5.7B | $5.2B | $5.9B | $6.1B |
| Operating Income | -$1.1B | -$32M | $717M | $1.6B | $1.8B |
| Operating Margin | -5.3% | -0.1% | 2.7% | 5.2% | 5.4% |
| Interest Expense | $4M | $6M | $6M | $3M | $1M |
| Income Before Tax | -$253M | $551M | $939M | $1.6B | $2.2B |
| Tax Expense | $13M | $14M | $56M | $128M | $326M |
| Net Income | -$266M | $536M | $883M | $1.4B | $1.9B |
| Net Margin | -1.3% | 2.0% | 3.3% | 4.7% | 5.7% |
| EPS (Diluted) | $-0.02 | $0.04 | $0.06 | $0.09 | $0.11 |
| EBITDA | -$188M | -$24M | $999M | $1.6B | $1.8B |
| Shares Outstanding | 13.48B | 13.54B | 14.09B | 16.14B | 16.20B |